Stock Fundamentals

Company Information

Company Name
Kalvista Pharmaceuticals Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN: US4834971032
CIK: 0001348911
CUSIP: 141384107
Currency: USD
Full Time Employees: 275
Phone: 857 999 0075
Fiscal Year End: April
IPO Date: Apr 09, 2015
Description:

As of June 11, 2026, KalVista Pharmaceuticals, Inc. was taken private. KalVista Pharmaceuticals, Inc. operates as a biopharmaceutical company that develops oral therapies for rare diseases in worldwide markets. It offers sebetralstat, a novel, oral, on-demand treatment for hereditary angioedema (HAE), and an oral Factor XIIa inhibitor program. KalVista Pharmaceuticals, Inc. was formerly known as KalVista Pharmaceuticals Ltd. and changed its name to KalVista Pharmaceuticals, Inc. in November 2016. KalVista Pharmaceuticals, Inc. is headquartered in Framingham, Massachusetts. As of June 11, 2026, KalVista Pharmaceuticals, Inc. operates as a subsidiary of Chiesi Farmaceutici S.p.A.

Address:

200 Crossing Boulevard, Framingham, MA, United States, 01702

Directors & Officers

Name Title Year Born
Mr. Benjamin L. Palleiko CEO & Director 1966
Mr. Brian Piekos Chief Financial Officer 1975
Mr. Bilal Arif Chief Operating Officer 1972
Dr. Paul K. Audhya M.B.A., M.D. Chief Medical Officer 1972
Mr. Ryan Baker Head of Investor Relations NA
Mr. Brian Krex J.D. General Counsel 1968
Dr. Christopher L. Hamblett Ph.D. Senior Vice President of Corporate Development NA
Ms. Linea Aspesi Chief People Officer 1970
Ms. Rachel M. Morten Senior Vice President of Regulatory Affairs & QA NA
Dr. Christopher M. Yea Ph.D. Chief Development Officer 1964

Insider Trading

Date Insider Name Title Transaction Type Shares Price Value
Apr 17, 2026 Brian Piekos N/A Sale 1.86K $20.22 $37.65K
Apr 17, 2026 Nicole Sweeny N/A Sale 1.86K $20.22 $37.65K
Apr 17, 2026 Paul K Audhya N/A Sale 2.69K $20.22 $54.31K
Apr 17, 2026 Benjamin L Palleiko N/A Sale 9.55K $20.22 $193.10K
Mar 26, 2026 Venrock Healthcare Capital Par N/A Sale 39.99K $18.28 $730.94K
Mar 25, 2026 Venrock Healthcare Capital Par N/A Sale 174.65K $16.95 $2.96M
Mar 09, 2026 Benjamin L Palleiko N/A Sale 6.69K $16.08 $107.62K
Feb 23, 2026 Brian Piekos N/A Sale 1.77K $15.57 $27.51K
Feb 23, 2026 Paul K Audhya N/A Sale 5.35K $15.57 $83.36K
Feb 23, 2026 Nicole Sweeny N/A Sale 3.98K $15.57 $61.89K
Feb 23, 2026 Benjamin L Palleiko N/A Sale 10.03K $15.57 $156.23K
Feb 18, 2026 Benjamin L Palleiko N/A Sale 1.04K $15.00 $15.57K
Feb 18, 2026 Paul K Audhya N/A Sale 1.16K $15.00 $17.45K
Feb 12, 2026 Benjamin L Palleiko N/A Sale 3.35K $15.70 $52.66K
Dec 08, 2025 Benjamin L Palleiko N/A Sale 7.29K $16.51 $120.42K
Nov 24, 2025 Benjamin L Palleiko N/A Sale 10.94K $13.45 $147.14K
Nov 24, 2025 Paul K Audhya N/A Sale 5.30K $13.45 $71.23K
Nov 24, 2025 Brian Piekos N/A Sale 4.47K $13.45 $60.13K
Nov 12, 2025 Benjamin L Palleiko N/A Sale 3.33K $11.55 $38.44K
Sep 08, 2025 Benjamin L Palleiko N/A Sale 7.29K $15.84 $115.54K

Institutional Holders

Holder Name Shares Date Reported % Out Value % Change
VR Adviser, LLC 6.47M Mar 31, 2026 12.16% $4.86 -3.78%
Frazier Life Sciences Management, L.P. 4.96M Mar 31, 2026 9.32% $2.57 -1.56%
Suvretta Capital Management, LLC 4.77M Mar 31, 2026 8.96% $2.45 0.00%
TANG CAPITAL MANAGEMENT LLC 4.57M Mar 31, 2026 8.59% $4.68 0.00%
BlackRock Inc 3.80M Mar 31, 2026 7.13% $0.00 1.11%
SILVERARC CAPITAL MANAGEMENT, LLC 2.88M Mar 31, 2026 5.40% $5.91 18.51%
Capital World Investors 2.81M Mar 31, 2026 5.28% $0.01 0.00%
Vanguard Group Inc 2.51M Dec 31, 2025 4.71% $0.00 0.32%
Point72 Asset Management, L.P. 2.14M Mar 31, 2026 4.01% $0.06 -6.43%
State Street Corp 1.96M Mar 31, 2026 3.67% $0.00 2.31%
Millennium Management LLC 1.91M Mar 31, 2026 3.59% $0.02 -33.99%
Vestal Point Capital LP 1.85M Mar 31, 2026 3.47% $1.04 -2.12%
Parkman Healthcare Partners LLC 1.84M Mar 31, 2026 3.45% $3.81 3.79%
Vanguard Capital Management, LLC 1.83M Mar 31, 2026 3.44% $0.00 0.00%
Kynam Capital Management, LP 1.82M Mar 31, 2026 3.42% $2.26 0.55%
Woodline Partners LP 1.51M Mar 31, 2026 2.84% $0.11 -21.40%
Octagon Capital Advisors LP 1.45M Mar 31, 2026 2.72% $3.23 13.87%
Squadron Capital Management LLC 1.30M Mar 31, 2026 2.44% $9.59 85.73%
Emerald Advisers, LLC 1.26M Mar 31, 2026 2.37% $0.81 -5.70%
Armistice Capital, LLC 1.24M Mar 31, 2026 2.32% $0.44 54.50%

Shares Statistics

Shares Outstanding: 53.24M
Shares Float: 38.18M
% Insiders: 172.20%
% Institutions: 13,687.50%
Short % Float: 14.37%

Fund Holdings

Rank Holder Name Shares Held % of Shares Change Date Reported
1 American Funds SMALLCAP World A 2.81M 5.28% ▲ 0.00% Mar 31, 2026
2 Vanguard Total Stock Mkt Idx Inv 1.35M 2.54% ▲ 0.00% Apr 30, 2026
3 State Street® SPDR® S&P® Biotech ETF 1.19M 2.24% ▼ 0.61% May 31, 2026
4 iShares Russell 2000 ETF 914.71K 1.72% ▲ 0.94% May 29, 2026
5 MEDICAL BioHealth EUR Acc 861.55K 1.62% ▼ 11.90% Apr 30, 2026
6 apo Medical Opportunities R 771.44K 1.45% ▼ 0.45% Apr 30, 2026
7 International Biotechnology Ord 746.05K 1.40% ▼ 36.33% Feb 28, 2026
8 AZ InvestEd Ivy Small Cap Growth E 497.47K 0.93% ▲ 40.81% Apr 30, 2026
9 Vanguard Institutional Extnd Mkt Idx Tr 442.25K 0.83% ▲ 0.57% Apr 30, 2026
10 Impax Small Cap Institutional 400.00K 0.75% ▲ 0.00% Apr 30, 2026

Valuation Metrics

Enterprise Value: $1.30B
Trailing P/E: 0.00
Forward P/E: 25.45

Financial Highlights

Market Cap: $1.44B
EBITDA: $-138.45M
PEG Ratio: $0.00
Book Value: $-0.38
Earnings/Share: $-3.94
Profit Margin: -118.74%
Operating Margin: -57.37%
ROA (TTM): -60.98%
ROE (TTM): -190.18%
Revenue (TTM): $114.48M
Revenue/Share (TTM): $2.11
Earnings Growth (YOY): 0.00%
Revenue Growth (YOY): 30.70%

Stock Price History

1 Year Price History

2 Years Price History

5 Years Price History

10 Years Price History

Financial Charts

Revenue & Net Income (Yearly)

Revenue & Net Income (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Yearly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Earnings Per Share (EPS) History

Financial Ratios

Balance Sheet (Yearly)

Financial Ratios

Date Current Ratio Debt/Equity Debt/Assets Interest Coverage Debt/EBITDA
2026-04-30 5.58x -51.95x 1.01x -8.88x -0.94x
2025-04-30 5.35x 0.02x 0.62x -32.50x -0.01x
2024-04-30 9.90x 0.01x 0.12x N/A -0.01x
2023-04-30 11.46x 0.01x 0.12x -6.17x -0.01x
2022-04-30 16.73x 0.01x 0.09x -88.64x -0.01x
2021-04-30 27.04x 0.00x 0.05x -64.15x -0.02x
2020-04-30 11.49x 0.01x 0.09x -3.71x -0.01x
2019-04-30 6.40x 0.00x 0.18x -3.25x 0.00x
2018-04-30 2.56x 0.01x 0.56x -6.45x -0.02x
2017-04-30 11.35x 0.00x 0.09x -5.98x 0.00x
2016-04-30 7.59x 0.13x 0.13x -4.05x -0.18x
2016-03-31 12.83x 0.11x 0.13x N/A -0.71x
2015-12-31 12.86x 0.09x 0.13x N/A -0.19x
2015-04-30 0.65x -0.10x 7.65x -9.37x -0.55x
2014-12-31 0.65x -0.46x 1.70x N/A -0.18x
2014-04-30 2.51x -0.09x 4.34x -12.88x -0.58x
2013-04-30 2.71x -0.09x 4.32x -7.16x -1.53x

📦 Raw API Data (JSON Explorer)

Watchlist

0

No stocks in watchlist

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KALV.US!